UNC Researchers Report Promising Advances Toward First Brain‑Targeting Enzyme Therapy for Hunter Syndrome
- January 15, 2026
Fast-Track FDA Review Accelerates Path to First Treatment for Alzheimer’s-Related Agitation
FDA Approves First At-Home Brain Stimulation Device for Depression
Breakthrough Treatment for Prader-Willi Syndrome Validated in Peer-Reviewed Journal
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
The FDA has approved the first-ever at-home brain stimulation device for the treatment of depression. Read more here:
patientworthy.com/2026/01/14/fda-approves-first-at-home-brain-stimulation-device-for-depression/
Hidradenitis suppurativa awareness matters because this condition is often misunderstood, dismissed, or diagnosed late. For many people, it’s not “just a skin issue” — it can affect mobility, mental health, work, and daily life. Education helps reduce stigma, encourages earlier care, and reminds people living with HS that they’re not alone! #HidradenitisSuppurativa #HS #RareDisease #ShareYourStory #PatientWorthy
We're honored to share Missy's story about her daughter Eden, who's living with dwarfism due to achondroplasia. Read here:
Our Achondroplasia Journey: What I Wish I’d Known When My Daughter Was Diagnosed – Patient Worthy
patientworthy.com
Our Achondroplasia Journey: What I Wish I’d Known When My Daughter Was Diagnosed Post author:Austin Newman Post published:January 13, 2026 Post category:Achondroplasia Editor’s Note: Patient Worth...
